Philosophy/Values
Innovation is a driving force for our company. As a result, we are continuously licensing and/or acquiring new products and solutions aimed at addressing the essential needs of consumers, patients, and health care partners.
Improving Quality of Life, One Prescription at a Time
Medexus Pharmaceuticals Inc. is a leading innovative and rare disease pharmaceutical company with a focus on the therapeutic areas of rheumatology, auto-immune disease, specialty oncology, allergy, and pediatric diseases.
We provide market-leading prescription and over the counter brands to patients and healthcare professionals, which we believe greatly enhances quality of life and promotes a healthy lifestyle.
We have a strong North American commercial platform and we currently operate through two unique segments: Medexus Pharma Canada and Medexus Pharma USA.
Our Divisions
We have a strong North American commercial platform and currently operate through two segments: Medexus Pharma Canada and Medexus Pharma USA.
View DivisionsOur Growth Strategy
Our strategy is to drive organic growth by leveraging our existing product portfolio, supporting recent and future product launches, acquiring and/or licensing new products, and through further development of existing molecules to better meet the needs of patients.
View Growth StrategyLatest Financial Results
Q3 2023
Quarter Ended Dec 31, 2022
Experienced Leadership
We have an experienced leadership team comprised of senior executives with extensive commercial expertise in numerous therapeutic areas from within pharma companies, both large and small.
Careers at Medexus
At Medexus Pharmaceuticals, we foster a collaborative work environment where every individual has the opportunity to grow professionally and personally. We actively seek to hire hard-working individuals who are eager to develop their talents and share their innovative ideas.
View Careers